Methods and compositions for treating activated g-alpha q mutant cancers or melanocytic malignancies
US-2021403864-A1 · Dec 30, 2021 · US
Memorial Sloan Kettering Cancer Center was listed as an assignee on 190 patent publications in 2021.
| Metric | Value |
|---|---|
| Company | Memorial Sloan Kettering Cancer Center |
| Year | 2021 |
| Patents | 190 |
Representative publications for Memorial Sloan Kettering Cancer Center in 2021.
US-2021403864-A1 · Dec 30, 2021 · US
US-2021406611-A1 · Dec 30, 2021 · US
US-2021403597-A1 · Dec 30, 2021 · US
US-11207374-B2 · Dec 28, 2021 · US
US-11208446-B2 · Dec 28, 2021 · US
Most common classification codes for Memorial Sloan Kettering Cancer Center in 2021.
| CPC | Patents |
|---|---|
| A61P35/00 | 88 |
| A61K2039/505 | 42 |
| A61K45/06 | 41 |
| C07K2317/622 | 37 |
| A61K40/11 | 34 |
Navigate to parent entity pages.